Quote:
Originally Posted by Harry Z
James Mullen knows what needs to be known within Biogen and especially with Tysabri. Although there are no additional cases of PML that have been reported, that doesn't mean that there hasn't been. Rumours abound that other issues with Tysabri are brewing but until they are confirmed I will not say what they are.
Bottom line...I don't now and never have trusted what Biogen has told us from the beginning about Tysabri. I just hope that the MS patients that are using it don't end up with more problems that they already have with the disease.
Harry
|
Harry
Then why bother posting anything?
It's unsubstantiated posts like this that get the rumormongers going. If you have something substantial to post then post it...don't post something -- gee I heard...and let it go unsupported. Anyone can do that. I could post that I overheard two neurologists talking about a patient in the doctor's lounge yada yada yada and it would be worthless gossip.
The whole point of the TOUCH program is to track and report PML. If you think for one minute that there has been a case of PML and Tysabri unreported, then I do believe you are WRONG. And that, Harry, is something you can take to the bank and cash. I worked with the FDA and the RiskMAP committee to make sure the tracking procedure works...if you have a problem with the system you should be taking it up with the committee...not making innuendo here.
This post of yours is inflammatory and totally unnecessary, in my opinion.
In other words, I disagree with your comments. I can back mine up with names, dates, and reports. Can you? I didn't think so.